Mandate

Vinge has assisted Boliden in the acquisition of the Neves-Corvo and Zinkgruvan mines from Lundin Mining

Boliden has entered into a definitive agreement with Lundin Mining to acquire the Neves-Corvo mine in Portugal and the Zinkgruvan mine in Sweden. The upfront cash consideration for the entities is USD 1,300 m plus contingent payments that can reach up to USD 150 m, on a cash and debt-free basis. The transaction, that considerably strengthens Boliden's mine production as well as internal zinc and copper concentrate supply, is subject to customary regulatory approvals.

Vinge's M&A team was led by Ulrich Ziche and consisted of Maria Dahlin Kolvik, Egil Svensson, and Helena Liljenberg (M&A), Johan Cederblad (Environment), Niclas Winnberg (Real Estate), Emil Lindwall and Louisa Fagarasan (Employment), Victor Ericsson (Tax), Mario Saad (Commercial Agreements), and Johanna Engström (Transaction Support), while the Capital Markets team was led by Jesper Schönbeck and consisted of Amanda Knutsson, Joel Wahlberg, Joel Magnusson, and Adrian Filipovic.

For details of the transaction reference is made to Boliden’s press release, find it here

Related

Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)

DTG operates 31 clinics and 8 dental laboratories in the Netherlands. Oral Care is a portfolio company of Axcel VI and operates a network of dental clinics in Sweden, Norway and the Netherlands. To support this expansion, Axcel VII is joining Axcel VI as a shareholder in Oral Care.
February 19, 2025

Vinge advises Gotlandsbolaget in connection with off-take agreement regarding biogas

Vinge has advised Rederiaktiebolaget Gotland (Gotlandsbolaget) in connection with the entry into of a strategic off-take agreement, which secures the long-term supply of biogas for the Gotland ferry service traffic.
February 17, 2025

Vinge advises HAKI Safety AB in connection with the acquisition of Trimtec

Trimtec is a Swedish distributor of high-tech precision equipment.
February 14, 2025